IRadimed Corporation (IRMD)

NASDAQ: IRMD · IEX Real-Time Price · USD
42.39
+0.56 (1.34%)
Feb 23, 2024, 4:00 PM EST - Market closed
1.34%
Market Cap 534.35M
Revenue (ttm) 62.97M
Net Income (ttm) 16.33M
Shares Out 12.61M
EPS (ttm) 1.30
PE Ratio 32.61
Forward PE 26.78
Dividend n/a
Ex-Dividend Date n/a
Volume 73,400
Open 41.70
Previous Close 41.83
Day's Range 41.26 - 44.08
52-Week Range 36.12 - 51.04
Beta 0.83
Analysts n/a
Price Target n/a
Earnings Date Feb 8, 2024

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensor... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 16, 2014
Employees 123
Stock Exchange NASDAQ
Ticker Symbol IRMD
Full Company Profile

Financial Performance

In 2022, IRadimed's revenue was $53.30 million, an increase of 27.48% compared to the previous year's $41.81 million. Earnings were $12.83 million, an increase of 37.56%.

Financial Statements

News

IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results

WINTER SPRINGS, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three months and year ended December 31, 2023....

17 days ago - GlobeNewsWire

IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.

WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market op...

24 days ago - GlobeNewsWire

IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue

WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) --  IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible medical de...

6 weeks ago - GlobeNewsWire

IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference

WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical dev...

7 weeks ago - GlobeNewsWire

IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share

WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per sh...

2 months ago - GlobeNewsWire

IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results

WINTER SPRINGS, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30, 2023...

4 months ago - GlobeNewsWire

IRADIMED CORPORATION to Participate at Upcoming Investor Conferences

WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences...

6 months ago - GlobeNewsWire

IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results

WINTER SPRINGS, Fla., Aug. 03, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three and six months ended June 30, 2023. The...

7 months ago - GlobeNewsWire

IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd

WINTER SPRINGS, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market op...

7 months ago - GlobeNewsWire

IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes

WINTER SPRINGS, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), was recently named on Forbes' latest list of America's Best Small Companies for 2023. Iradim...

10 months ago - GlobeNewsWire

IRADIMED CORPORATION Announces First Quarter 2023 Financial Results

WINTER SPRINGS, Fla., May 04, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2023. The Company...

10 months ago - GlobeNewsWire

IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th

WINTER SPRINGS, Fla., April 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market op...

10 months ago - GlobeNewsWire

IRADIMED CORPORATION To Present at the 35th Annual Roth Conference

WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Issues Urgent Medical Device Correction

Letter Notifying Customers of Potential Issues with MRidium 1057 MRI Syringe Adapter Set Letter Notifying Customers of Potential Issues with MRidium 1057 MRI Syringe Adapter Set

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend

WINTER SPRINGS, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today its financial results for the fourth quarter and year ended December 31, 202...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd

WINTER SPRINGS, Fla., Jan. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market op...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022

WINTER SPRINGS, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced selected preliminary financial results for the fourth quarter that ended Dec...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results

WINTER SPRINGS, Fla., Nov. 03, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30, 2022...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA

Announces Preliminary Financial Results for Third Quarter 2022 Announces Preliminary Financial Results for Third Quarter 2022

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors

WINTER SPRINGS, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced the appointment of Hilda Scharen-Guivel to the Iradimed Board of Directors, ...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results

WINTER SPRINGS, Fla., July 29, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three and six months ended June 30, 2022. The...

1 year ago - GlobeNewsWire

UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market op...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market op...

1 year ago - GlobeNewsWire

IRADIMED Names John F. Glenn Chief Financial Officer

WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Announces First Quarter 2022 Financial Results

WINTER SPRINGS, Fla., April 29, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2022. The Compa...

1 year ago - GlobeNewsWire